Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

RCUS – arcus biosciences, inc. (US:NYSE)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RCUS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/13
12:23 pm
rcus
Rating for RCUS
Low Report
Rating for RCUS
Report
1/13
12:23 pm
rcus
Rating for RCUS
Low Report
Rating for RCUS
Report
1/13
12:23 pm
rcus
Rating for RCUS
Low Report
Rating for RCUS
Report
1/12
04:30 pm
rcus
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
Medium Report
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
Report
1/12
04:30 pm
rcus
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
Medium Report
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
Report
1/12
04:30 pm
rcus
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
Medium Report
Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs
Report
1/8
07:10 am
rcus
Rating for RCUS
Medium Report
Rating for RCUS
Report
1/8
07:10 am
rcus
Rating for RCUS
Medium Report
Rating for RCUS
Report
1/8
05:03 am
rcus
Arcus Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
Medium Report
Arcus Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
Report
1/8
05:03 am
rcus
Arcus Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
Medium Report
Arcus Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
Report
12/15
08:44 am
rcus
Arcus Biosciences (NYSE:RCUS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low Report
Arcus Biosciences (NYSE:RCUS) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Report
12/12
04:08 pm
rcus
Arcus Biosciences (NYSE:RCUS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low Report
Arcus Biosciences (NYSE:RCUS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Report
10/30
11:18 am
rcus
Rating for RCUS
Low Report
Rating for RCUS
Report
10/30
11:18 am
rcus
Rating for RCUS
Low Report
Rating for RCUS
Report
10/30
11:18 am
rcus
Rating for RCUS
Low Report
Rating for RCUS
Report
10/29
03:50 pm
rcus
Rating for RCUS
Low Report
Rating for RCUS
Report
10/29
03:50 pm
rcus
Rating for RCUS
Low Report
Rating for RCUS
Report
10/20
09:35 am
rcus
Rating for RCUS
Medium Report
Rating for RCUS
Report
10/20
09:35 am
rcus
Rating for RCUS
Medium Report
Rating for RCUS
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0